CSIMarket


Biomarin Pharmaceutical Inc  (BMRN)
Other Ticker:  
 

Biomarin Pharmaceutical Inc

BMRN's Fundamental analysis








Looking into Biomarin Pharmaceutical Inc growth rates, revenue grew by 20.22 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 714

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Biomarin Pharmaceutical Inc realized net income compared to net loss a year ago in IV. Quarter 2023

More on BMRN's Growth


Biomarin Pharmaceutical Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Biomarin Pharmaceutical Inc PEG ratio is at 5.42 Company is currently trading with Price to Cash flow multiple of 558.2 in trailing twelve-month period.
Company
101.12
PE TTM   
Industry
361.01
PE TTM    
Company's Price to Sales ratio is at 7.06.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.35.


More on BMRN's Valuation
 
 Total Debt (Millions $) 1,087
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 700,008
 Net Income/Employee (TTM) $ 48,508
 Receivable Turnover (TTM) 4.01
 Tangible Book Value (Per Share $) 23.15

Biomarin Pharmaceutical Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Biomarin Pharmaceutical Inc PEG ratio is at 5.42 Company is currently trading with Price to Cash flow multiple of 558.2 in trailing twelve-month period.
Company
101.12
PE TTM   
Industry
361.01
PE TTM    
Company's Price to Sales ratio is at 7.06.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.35.

Biomarin Pharmaceutical Inc Price to Book Ratio is at 3.45 lower than Indusry Avg. of 1523.03. and higher than S&P 500 Avg. of 0.01

More on BMRN's Valuation

  Market Capitalization (Millions $) 17,079
  Shares Outstanding (Millions) 193
  Employees 3,456
  Revenues (TTM) (Millions $) 2,419
  Net Income (TTM) (Millions $) 168
  Cash Flow (TTM) (Millions $) 31
  Capital Exp. (TTM) (Millions $) -108
  Total Debt (Millions $) 1,087
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 700,008
  Net Income/Employee(TTM) $ 48,508
  Receivable Turnover Ratio (TTM) 4.01
  Tangible Book Value (Per Share $) 23.15

  Market Capitalization (Millions $) 17,079
  Shares Outstanding (Millions) 193
  Employees 3,456
  Revenues (TTM) (Millions $) 2,419
  Net Income (TTM) (Millions $) 168
  Cash Flow (TTM) (Millions $) 31
  Capital Exp. (TTM) (Millions $) -108


    BMRN's Profitability Comparisons
Biomarin Pharmaceutical Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 2.2 % from 4.41 % in III. Quarter.

Biomarin Pharmaceutical Inc net profit margin of 3.15 % is currently ranking no. 42 in Major Pharmaceutical Preparations industry, ranking no. 148 in Healthcare sector and number 1760 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.51
  Total Debt to Equity (MRQ) 0.22
  Tangible Leverage Ratio (MRQ) 0.42
  Asset Turnover Ratio (TTM) 0.36
  Inventory Turnover Ratio (TTM) 0.51



Biomarin Pharmaceutical Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2023 to 2.2 % from 4.41 % in III. Quarter.

Biomarin Pharmaceutical Inc net profit margin of 3.15 % is currently ranking no. 42 in Major Pharmaceutical Preparations industry, ranking no. 148 in Healthcare sector and number 1760 in S&P 500.

More on BMRN's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com